AxoGen (AXGN) Misses Q1 EPS by 2c

AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $22.33 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• Corpay agrees to $100M FTC settlement over marketing practices